Replies to post #2421 on Nascent Biotech Inc. (NBIO)

[fink]

Multi dollars.
55m float snd only in phase 1 clinical trials?

This has a long road ahead of it before you see a buy out offer from Gilead. If they see positive phase 2 trials, they might get a collaboration from one of the big boys. These get awful fun then..

You might get .40+ on positive phase 2 trials. Positive phase 3 with FDA approval you will see multi double digit dollars.